About Capsid Biotechnology
Capsid Biotechnology develops research reagents, laboratory consumables and custom synthesis services for life science research. The company supports scientists with high-purity synthetic small molecules, bioactive peptides, natural products, biochemicals and antibody-based reagents. Its expertise in chemical synthesis enables the production of complex molecular targets from early research quantities through to larger-scale requirements. Comprehensive analytical characterisation, including HPLC, NMR and mass spectrometry data, supports reagent verification and experimental reproducibility. Capsid Biotechnology serves a broad range of applications across cell biology, drug discovery, chemical biology, immunology, oncology and translational research.
The company’s portfolio includes synthetic small molecules, bioactive compound libraries, antiviral compounds, research primary antibodies, phospho-specific antibodies, biosimilar and reference antibodies, and in vivo antibodies. In addition, they provide custom synthesis services for specialised research compounds, supported by analytical testing and quality documentation. These products support target validation, pathway analysis, screening workflows, biomarker research and preclinical investigation. Laboratory consumables, including microtome blades, slides and cassettes, further support routine research and histology workflows.
Europa Biosite’s subsidiaries distribute for Capsid Biotechnology in Ireland, Switzerland and the United Kingdom.